ArticleHuman vaccines & immunotherapeutics2019

An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis.

Angela R Wateska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.